|
JAMA Network Open |
Effect of Text Message Reminders and Vaccine Reservations on Adherence to a Health System COVID-19 Vaccination Policy - A Randomized Clinical Trial |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake - A Randomized Clinical Trial |
1 |
Yes |
6/17/2025 |
|
JAMA Network Open |
Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years |
1 |
Yes |
8/8/2025 |
|
JAMA Network Open |
Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge - A Cohort Study and Randomized Comparative Effectiveness Trial |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Emotional Exhaustion Among US Health Care Workers Before and During the COVID-19 Pandemic, 2019-2021 |
1 |
Yes |
9/23/2025 |
|
JAMA Network Open |
Enhancing Postmarketing Surveillance of Medical Products With Large Language Models |
1 |
Yes |
8/16/2027 |
|
JAMA Network Open |
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes |
1 |
Yes |
9/23/2025 |
|
JAMA Network Open |
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA Vaccinated and Nonvaccinated Individuals in Quebec, Canada |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England |
1 |
Yes |
11/7/2025 |
|
JAMA Network Open |
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Evaluation of Age Patterns of COVID-19 Mortality by Race and Ethnicity From March 2020 to October 2021 in the US |
1 |
Yes |
5/31/2025 |
|
JAMA Network Open |
Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Evaluation of Risk Factors for Conversion From a COVID-19 Household Contact to a Case in New York City, August 1, 2020, to July 31, 2021 |
1 |
Yes |
9/19/2025 |
|
JAMA Network Open |
Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England |
1 |
Yes |
9/19/2025 |
|
JAMA Network Open |
Evaluation of Trends in Alcohol Use Disorder Related Mortality in the US Before and During the COVID-19 Pandemic |
1 |
Yes |
5/9/2025 |
|
JAMA Network Open |
Evidence From the USPSTF and New Approaches to Evaluate Interventions to Prevent Child Maltreatment |
1 |
Yes |
7/8/2027 |
